O'Keeffe Charles B

Director at Catalyst Pharmaceutical Partners, Inc. · on record since Oct 23, 2006

Insider trading activity of O'Keeffe Charles B

Transactions on record: 106; since Mar 26, 2007

Open-market buys: 34; $524.3K

Open-market sells: 1; $1.4M

Companies traded: 1; last filing Feb 19, 2025

Figures computed from official regulatory filings — methodology.

Companies where O'Keeffe Charles B has traded

Catalyst Pharmaceutical Partners, Inc.106 tx · $2.7M · Feb 19, 2025

Track record of O'Keeffe Charles B

Statistical track record

Free

Open-market buys: 35

Last buy: Sep 30, 2020

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of O'Keeffe Charles B

Co-insiders of O'Keeffe Charles B

Andrews William T.Catalyst Pharmaceutical Partners, Inc.
BIOMARIN PHARMACEUTICAL INCCatalyst Pharmaceutical Partners, Inc.
BRENNAN DANIELCatalyst Pharmaceutical Partners, Inc.
COELHO PHILIP HCatalyst Pharmaceutical Partners, Inc.
Curran Daniel J.Catalyst Pharmaceutical Partners, Inc.
DALY RICHARD JCatalyst Pharmaceutical Partners, Inc.
Del Carmen JeffreyCatalyst Pharmaceutical Partners, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Catalyst Pharmaceutical Partners, Inc.	Feb 19, 2025	Exercise	4,000	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 19, 2025	ExerciseD	-4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 31, 2024	Exercise	1,333	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 31, 2024	ExerciseD	-1,333	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	ExerciseD	-1,413	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	Exercise	1,413	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	Exercise	40,000	4.01 USD	$160.4K	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	ExerciseD	-40,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Nov 25, 2024	AwardD	23,248	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Nov 25, 2024	AwardD	2,841	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 16, 2024	Exercise	4,000	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 16, 2024	ExerciseD	-4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 3, 2024	ExerciseD	-60,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 3, 2024	Exercise	60,000	1.13 USD	$67.8K	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2023	ExerciseD	-1,333	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2023	Exercise	1,333	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 12, 2023	AwardD	29,524	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 12, 2023	AwardD	4,240	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 17, 2023	ExerciseD	-4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 17, 2023	Exercise	4,000	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 27, 2023	ExerciseD	-50,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 27, 2023	Exercise	50,000	0.79 USD	$39.5K	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2022	AwardD	15,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2022	AwardD	4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 8, 2022	ExerciseD	-1,334	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Catalyst Pharmaceutical Partners, Inc.	Feb 19, 2025	Exercise	4,000	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 19, 2025	ExerciseD	-4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 31, 2024	Exercise	1,333	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 31, 2024	ExerciseD	-1,333	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	ExerciseD	-1,413	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	Exercise	1,413	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	Exercise	40,000	4.01 USD	$160.4K	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 11, 2024	ExerciseD	-40,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Nov 25, 2024	AwardD	23,248	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Nov 25, 2024	AwardD	2,841	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 16, 2024	Exercise	4,000	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 16, 2024	ExerciseD	-4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 3, 2024	ExerciseD	-60,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 3, 2024	Exercise	60,000	1.13 USD	$67.8K	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2023	ExerciseD	-1,333	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2023	Exercise	1,333	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 12, 2023	AwardD	29,524	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 12, 2023	AwardD	4,240	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 17, 2023	ExerciseD	-4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Feb 17, 2023	Exercise	4,000	—	—	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 27, 2023	ExerciseD	-50,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Jan 27, 2023	Exercise	50,000	0.79 USD	$39.5K	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2022	AwardD	15,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 29, 2022	AwardD	4,000	0.00 USD	$0	SEC
Catalyst Pharmaceutical Partners, Inc.	Dec 8, 2022	ExerciseD	-1,334	0.00 USD	$0	SEC